Simultaneous measurement of extracellular dopamine and dopamine transporter occupancy by cocaine analogs in squirrel monkeys

Synapse

Volumn 66, Issue 6, 2012, Pages 501-508

  Kimmel, Heather L ^a,b   Nye, Jonathon A ^b   Voll, Ronald ^b   Mun, Jiyoung ^b   Stehouwer, Jeffrey ^b   Goodman, Mark M ^b   Votaw, John R ^b   Carroll, F I ^c   Howell, Leonard L ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RTI INTERNATIONAL   (United States)

Author keywords

in vivo microdialysis; Monoamine; Psychostimulant; Trafficking; Transporter

Indexed keywords

3BETA (4 CHLOROPHENYL)TROPANE 2BETA (3 PHENYLISOXAZOL 5 YL)HYDROCHLORIDE; 3BETA (4 CHLOROPHENYL)TROPANE 2BETA [3 (4 METHYLPHENYL)ISOXAZOL 5 YL] HYDROCHLORIDE; 3BETA (4 METHYLPHENYL)TROPAN 2BETA CARBOXYLIC ACID CYCLOBUTYL ESTER HYDROCHLORIDE; COCAINE; COCAINE DERIVATIVE; DOPAMINE; DOPAMINE TRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CELL MEMBRANE; EXTRACELLULAR SPACE; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; SQUIRREL MONKEY;

ANIMALS; BRAIN; COCAINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; EXTRACELLULAR SPACE; MALE; MICRODIALYSIS; POSITRON-EMISSION TOMOGRAPHY; REINFORCEMENT (PSYCHOLOGY); SAIMIRI;

EID: 84859430495     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21536     Document Type: Article

References (50)

1. Bergman J, Madras BK, Johnson SE, Spealman RD. 1989. Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther 251: 150-155.
2. Bradberry CW, Nobiletti JB, Elsworth JD, Murphy B, Jatlow P, Roth RH. 1993. Cocaine and cocaethylene: Microdialysis comparison of brain drug levels and effects on dopamine and serotonin. J Neurochem 60: 1429-1435.
3. Breeman WA, Kwekkeboom DJ, Kooij PP, Bakker WH, Hofland LJ, Visser TJ, Ensing GJ, Lamberts SW, Krenning EP. 1995. Effect of dose and specific activity on tissue distribution of indium-111-pentetreotide in rats. J Nucl Med: Official publication, Soc Nucl Med 36: 623-627.
4. Carroll FI, Howell LL, Kuhar MJ. 1999. Pharmacotherapies for treatment of cocaine abuse: Preclinical aspects. J Med Chem 42: 2721-2736.
5. Chen R, Han DD, Gu HH. 2005. A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate. J Neurochem 94: 352-359.
6. Chi L, Reith ME. 2003. Substrate-induced trafficking of the dopamine transporter in heterologously expressing cells and in rat striatal synaptosomal preparations. J Pharmacol Exp Ther 307: 729-736.
7. Czoty PW, Justice JBJr, Howell LL. 2000. Cocaine-induced changes in extracellular dopamine determined by microdialysis in awake squirrel monkeys. Psychopharmacology 148: 299-306.
8. Daws LC, Callaghan PD, Moron JA, Kahlig KM, Shippenberg TS, Javitch JA, Galli A. 2002. Cocaine increases dopamine uptake and cell surface expression of dopamine transporters. Biochem Biophys Res Commun 290: 1545-1550.
9. Ferris MJ, Mateo Y, Roberts DC, Jones SR. 2011. Cocaine-insensitive dopamine transporters with intact substrate transport produced by self-administration. Biol Psychiatry 69: 201-207.
10. Goodman MM, Kilts CD, Keil R, Shi B, Martarello L, Xing D, Votaw J, Ely TD, Lambert P, Owens MJ, Camp VM, Malveaux E, Hoffman JM. 2000. 18F-labeled FECNT: A selective radioligand for PET imaging of brain dopamine transporters. Nucl Med Biol 27: 1-12.
11. Gorentla BK, Vaughan RA. 2005. Differential effects of dopamine and psychoactive drugs on dopamine transporter phosphorylation and regulation. Neuropharmacology 49: 759-768.
12. Gulley JM, Zahniser NR. 2003. Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands. Eur J Pharmacol 479: 139-152.
13. Heikkila RE, Manzino L. 1984. Behavioral properties of GBR12909, GBR13069, GBR13098: Specific inhibitors of dopamine uptake. Eur J Pharmacol 103: 241-248.
14. Howell LL, Carroll FI, Votaw JR, Goodman MM, Kimmel HL. 2007. Effects of combined dopamine and serotonin transporter inhibitors on cocaine self-administration in rhesus monkeys. J Pharmacol Exp Ther 320: 757-765.
15. 11C]AFM). Nucl Med Biol 31: 543-556.
16. Hurd YL, Herkenham M. 1993. Molecular alterations in the neostriatum of human cocaine addicts. Synapse 13: 357-369.
17. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang S-C, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE. 2007. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27: 1533-1539.
18. Kimmel HL, Carroll FI, Kuhar MJ. 2000. Dopamine transporter synthesis and degradation rate in rat striatum and nucleus accumbens using RTI-76. Neuropharmacology 39: 578-585.
19. Kimmel HL, Carroll FI, Kuhar MJ. 2001a. Locomotor stimulant effects of novel phenyltropanes in the mouse. Drug Alcohol Depend 65: 25-36.
20. Kimmel HL, Ivy Carroll F, Kuhar MJ. 2001b. Locomotor stimulant effects of novel phenyltropanes in the mouse. Drug Alcohol Depend 65: 25-36.
21. Kimmel HL, Carroll FI, Kuhar MJ. 2003. Withdrawal from repeated cocaine alters dopamine transporter protein turnover in the rat striatum. J Pharmacol Exp Ther 304: 15-21.
22. Kimmel HL, Negus SS, Ewing SB, Votaw JR, Goodman MM, Carroll FI, Mello NK, Howell LL. 2005. Behavioral pharmacology and pharmacokinetics of cocaine analogs in rhesus monkeys. Waikoloa, HI: Nature Publishing. p S147-S148.
23. Kimmel HL, O'Connor J A, Carroll FI, Howell LL. 2007. Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys. Pharmacol Biochem Behav 86: 45-54.
24. Kimmel HL, Negus SS, Wilcox KM, Ewing SB, Stehouwer J, Goodman MM, Votaw JR, Mello NK, Carroll FI, Howell LL. 2008. Relationship between rate of drug uptake in brain and behavioral pharmacology of monoamine transporter inhibitors in rhesus monkeys. Pharmacol Biochem Behav 90: 453-462.
25. Kuhar MJ, McGirr KM, Hunter RG, Lambert PD, Garrett BE, Carroll FI. 1999. Studies of selected phenyltropanes at monoamine transporters. Drug Alcohol Depend 56: 9-15.
26. Lammertsma AA, Hume SP. 1996. Simplified reference tissue model for PET receptor studies. Neuroimage 4: 153-158.
27. Letchworth SR, Nader MA, Smith HR, Friedman DP, Porrino LJ. 2001. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. J Neurosci 21: 2799-2807.
28. Lindsey KP, Wilcox KM, Votaw JR, Goodman MM, Plisson C, Carroll FI, Rice KC, Howell LL. 2004. Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging. J Pharmacol Exp Ther 309: 959-969.
29. Little KY, Elmer LW, Zhong H, Scheys JO, Zhang L. 2002. Cocaine induction of dopamine transporter trafficking to the plasma membrane. Mol Pharmacol 61: 436-445.
30. Malizia AL, Melichar JM, Brown DJ, Gunn RN, Reynolds A, Jones T, Nutt DJ. 1997. Demonstration of clomipramine and venlafaxine occupation at serotonin reuptake sites in man in vivo. J Psychopharmacol 11: 279-281.
31. Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ. 1984. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 15: 217-227.
32. Mortensen OV, Amara SG. 2003. Dynamic regulation of the dopamine transporter. Eur J Pharmacol 479: 159-170.
33. Press WH. 1989. Numerical recipes: The art of scientific computing. New York, NY: Cambridge University Press. p 702.
34. Reith MEA, Meisler BE, Sershen H, Lajtha A. 1986. Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochem Pharmacol 35: 1123-1129.
35. Ritz MC, Kuhar MJ. 1989. Relationship between self-administration of amphetamine and monoamine receptors in brain: Comparison with cocaine. J Pharmacol Exp Ther 248: 1010-1017.
36. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. 1987. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237: 1219-1223.
37. Rudnick G, Clark J. 1993. From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta 1144: 249-263.
38. SAMHSA U. 2007. Results from the 2006 National Survey on Drug Use and Health: National Findings. Rockville, MD: Office of Applied Studies.
39. Schmitt KC, Reith ME. 2010. Regulation of the dopamine transporter: Aspects relevant to psychostimulant drugs of abuse. Ann N Y Acad Sci 1187: 316-340.
40. Stafford D, LeSage MG, Rice KC, Glowa JR. 2001. A comparison of cocaine, GBR 12909, and phentermine self-administration by rhesus monkeys on a progressive-ratio schedule. Drug Alcohol Depend 62: 41-47.
41. Tella SR, Ladenheim B, Andrews AM, Goldberg SR, Cadet JL. 1996. Differential reinforcing effects of cocaine and GBR-12909: Biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system. J Neurosci 16: 7416-7427.
42. Vocci FJ, Acri J, Elkashef A. 2005. Medication development for addictive disorders: The state of the science. Am J Psychiatry 162: 1432-1440.
43. Votaw JR, Howell LL, Martarello L, Hoffman JM, Kilts CD, Lindsey KP, Goodman MM. 2002. Measurement of dopamine transporter occupancy for multiple injections of cocaine using a single injection of [F-18]FECNT. Synapse 44: 203-210.
44. Wilcox KM, Paul IA, Woolverton WL. 1999. Comparison between dopamine transporter affinity and self-administration potency of local anesthetics in rhesus monkeys. Eur J Pharmacol 367: 175-181.
45. Wilcox KM, Rowlett JK, Paul IA, Ordway GA, Woolverton WL. 2000. On the relationship between the dopamine transporter and the reinforcing effects of local anesthetics in rhesus monkeys: practical and theoretical concerns. Psychopharmacology (Berlin) 153: 139-147.
46. Wilcox KM, Kimmel HL, Lindsey KP, Votaw JR, Goodman MM, Howell LL. 2005. In vivo comparison of the reinforcing and dopamine transporter effects of local anesthetics in rhesus monkeys. Synapse 58: 220-228.
47. Wise RA, Bozarth MA. 1987. A psychomotor stimulant theory of addiction. Psychol Rev 94: 469-492.
48. Woolverton WL, Hecht GS, Agoston GE, Katz JL, Newman AH. 2001. Further studies of the reinforcing effects of benztropine analogs in rhesus monkeys. Psychopharmacology (Berlin) 154: 375-382.
49. Zahniser NR, Sorkin A. 2004. Rapid regulation of the dopamine transporter: Role in stimulant addiction? Neuropharmacology 47( Suppl 1): 80-91.
50. Zahniser NR, Sorkin A. 2009. Trafficking of dopamine transporters in psychostimulant actions. Semin Cell Dev Biol 20: 411-417.